Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 134
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06587295 | Intramuscular ACM-CpG Monotherapy in Patients With Advanced/Metastatic Solid Tumors With Prior Response to Immunotherapy Alone or in Combination With Chemotherapy | ||
| NCT07209501 | Evaluating the Feasibility and Acceptability of Inhalation Aromatherapy for Patients Undergoing Autologous Haematopoietic Stem Cell Transplant (HSCT) | ||
| NCT04230330 | Nivolumab in Combination With GDP/ L-asparaginase in NK/ T-cell Lymphoma | ||
| NCT03792867 | Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma | ||
| NCT00471484 | Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery | ||
| NCT04072107 | EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR) | ||
| NCT02408497 | Use of Non-invasive 4D Ultrasound Clarity System in Prostate IMRT/RapidArc Therapy | ||
| NCT06977360 | Feasibility, Acceptability and Preliminary Efficacy of the New Iteration of the Innovative Smartphone-based Care Solution for Women With Breast Cancer Undergoing Chemotherapy (iCareBreast+): A Pilot Study Research Proposal | ||
| NCT04946968 | Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers | ||
| NCT03093831 | Phase II Study of Ibrutinib in Patients With Relapsed or Refractory Marginal Zone Lymphoma | ||
| NCT06418412 | A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLC | ||
| NCT03188159 | Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer | ||
| NCT03033446 | Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular Carcinoma | ||
| NCT02435927 | ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin | ||
| NCT00731276 | Irinotecan in Treating Asian Patients With Solid Tumors | ||
| NCT04087473 | Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC | ||
| NCT04452084 | Phase 2 Trial in Multiple Brain Metastases Outcomes With HA-SIB-WBRT | ||
| NCT00589238 | Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by Surgery | ||
| NCT00870532 | Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer | ||
| NCT04738708 | Telegenetics or In-Person Genetic Counselling | ||
| NCT02720926 | Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric Cancer | ||
| NCT00690872 | Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer | ||
| NCT03200730 | A Novel Family Dignity Intervention (FDI) for Asian Palliative Care | ||
| NCT03212937 | Phase I Trial of Selinexor (KPT-330) and Ifosfamide, Carboplatin, Etoposide (ICE) in Peripheral T-cell Lymphoma | ||
| NCT05036902 | The Impact of Multimodality Treatment on Physical Functions and Quality of Life in Patients With Head and Neck Cancer | ||
| NCT04242251 | Novel Palliative Care Model for Advanced Cancer Patients: A Randomized Controlled Trial Study | ||
| NCT05211882 | ENABLE (Educate, Nurture, Advise, Before Life Ends) Intervention for Heart Failure (HF) Patients and Their Caregivers in Singapore | ||
| NCT06172595 | FET PET in Differentiating Tumour Progression From Pseudoprogression in High Grade Glioma | ||
| NCT06956248 | Innovating Access to Novel Therapies Through Standardized Prospective Integration of Response Evaluations (IMPACT-INSPIRE) | ||
| NCT05286437 | Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole | ||
| NCT04340024 | Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients | ||
| NCT05148572 | Prospective Cohort Study of Changes in Circulatory MicroRNA of Resected Hepatocellular Carcinoma | ||
| NCT02736305 | Use of Regorafenib in Recurrent Epithelial Ovarian Cancer | ||
| NCT05581550 | Somatostatin Receptor Imaging in NPC, EBV Related Cancers | ||
| NCT05198479 | Phase II 177Lu-DOTATATE Study in Metastatic NPC With a Safety Run-in | ||
| NCT00997906 | Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC | ||
| NCT00263484 | Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma | ||
| NCT00589186 | Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer | ||
| NCT04620954 | Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin | ||
| NCT01341834 | Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors | ||
| NCT05581979 | PSMA-PET Imaging of Salivary Gland Tumours and Other Rare Cancers | ||
| NCT04986748 | Using QPOP to Predict Treatment for Sarcomas and Melanomas | ||
| NCT01394315 | Diffuse Optical Tomography (DOT) for Monitoring Response to Neoadjuvant (Preoperative) Chemotherapy in Breast Cancer | ||
| NCT04961632 | Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376 | ||
| NCT04961489 | Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes | ||
| NCT04451603 | LiverMultiScan Analysis of MRI Scans in HCC | ||
| NCT02313298 | Stereotactic Body Radiotherapy for Organ Confined Prostate Cancer | ||
| NCT01228045 | A Study of Trastuzumab in Combination With TS-ONE & Cisplatin in First-line Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer | ||
| NCT02801734 | Enhancing Quality of Life in Patients (EQUIP) Intervention for Patients With Advanced Lung Cancer | ||
| NCT04912765 | Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC |
